Skip to main content
Premium Trial:

Request an Annual Quote

People In The News: Mar 26, 2010

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Frank Pitzer has been named CEO of Roche NimbleGen. Pitzer has been with Roche for more than eight years, most recently as head of divisional quality and regulatory affairs at Roche Diagnostics.

"Frank's leadership skills and extensive experience in the life science industry make him the perfect fit to guide Roche NimbleGen through the next stages of growth," Manfred Baier, head of Roche Applied Science, said in a statement. "His valuable insight and outstanding management experience will further entrench the company as a leading manufacturer of microarray technologies."

Bio-Rad Laboratories has appointed Ted Love to serve on its board of directors and on the board's audit committee. The move enabled the company to regain compliance with regulations of the New York Stock Exchange, which requires that a listed company have three independent directors on its audit committee. Love currently is executive VP of R&D at Onyx Pharmaceuticals, and from 2001 to 2009 he was president and CEO of Nuvelo. Love also previously spent six years in senior management at Genentech.

NanoString has tapped William Young to be executive chairman of its board of directors. Young formerly was CEO and chairman of Monogram Biosciences and he was COO at Genentech. He currently serves as chairman of the board of directors of Biogen, is chairman emeritus for BayBio, and he is a director at Theravance.

Complete Genomics has named Mark Sutherland senior VP of business development. He formerly was VP of genomics at Amersham Biosciences, where he focused on running the DNA sequencing, genotyping, and gene expression business. Sutherland recently was VP of business development at GenVault, and before that he was VP of strategic alliances for GE Healthcare's Discovery Systems Business.

Gen-Probe has named Brian McNamee, who is CEO of the drug company CSL, to re-join the company's board of directors. McNamee already served on the company's board of directors from 2002 to 2007. He has been CEO and managing director of CSL since 1990.

Promoted? Changing jobs? GenomeWeb wants to know. E-mail [email protected] to appear in People In The News, a weekly roundup of industry comings and goings.

The Scan

Germline-Targeting HIV Vaccine Shows Promise in Phase I Trial

A National Institutes of Health-led team reports in Science that a broadly neutralizing antibody HIV vaccine induced bnAb precursors in 97 percent of those given the vaccine.

Study Uncovers Genetic Mutation in Childhood Glaucoma

A study in the Journal of Clinical Investigation ties a heterozygous missense variant in thrombospondin 1 to childhood glaucoma.

Gene Co-Expression Database for Humans, Model Organisms Gets Update

GeneFriends has been updated to include gene and transcript co-expression networks based on RNA-seq data from 46,475 human and 34,322 mouse samples, a new paper in Nucleic Acids Research says.

New Study Investigates Genomics of Fanconi Anemia Repair Pathway in Cancer

A Rockefeller University team reports in Nature that FA repair deficiency leads to structural variants that can contribute to genomic instability.